GGrantIndex
← Search

Es Tiempo/It’s Time: A Multi-Channel Multi-Cultural Communication Campaign for Improvements in Education and Outcomes on Human Papilloma Virus Vaccinations and HPV Related Cancers in Vulnerable popula

$199,418P30FY2023CANIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07456436Trial NCT07339254Trial NCT07332312Trial NCT07312162Trial NCT07306338Trial NCT07279571Trial NCT07276048Trial NCT07259304Trial NCT07229443Trial NCT07186699Trial NCT07162194Trial NCT07082257Trial NCT07076147Trial NCT06500169Trial NCT06422455Trial NCT06420219Trial NCT06374251Trial NCT06338657Trial NCT06336928Trial NCT06336902Trial NCT06297265Trial NCT06191575Trial NCT06171607Trial NCT06132087Trial NCT06128525Trial NCT06067295Trial NCT06063928Trial NCT06063486Trial NCT06060873Trial NCT05989828Trial NCT05791448Trial NCT05786664Trial NCT05516485Trial NCT05514990Trial NCT05462561Trial NCT05340309Trial NCT04981834Trial NCT04941430Trial NCT04927559Trial NCT04832763Trial NCT04830735Trial NCT04752267Trial NCT04387084Trial NCT04387071Trial NCT04373044Trial NCT04318028Trial NCT04315701Trial NCT04162678Trial NCT03971266Trial NCT03921047Trial NCT03858205Trial NCT03789773Trial NCT03739801Trial NCT03698162Trial NCT03657641Trial NCT03594448Trial NCT03576963Trial NCT03568292Trial NCT03568266Trial NCT03563651Trial NCT03563352Trial NCT03552796Trial NCT03537690Trial NCT03519984Trial NCT03514927Trial NCT03492801Trial NCT03485794Trial NCT03412370Trial NCT03408561Trial NCT03353896Trial NCT03348137Trial NCT03344211Trial NCT03330821Trial NCT03300609Trial NCT03300401Trial NCT03284346Trial NCT03267680Trial NCT03257761Trial NCT03238664Trial NCT03234556Trial NCT03207854Trial NCT03176979Trial NCT03146871Trial NCT03137706Trial NCT03120390Trial NCT03111823Trial NCT03098277Trial NCT03092856Trial NCT03091842Trial NCT03091816Trial NCT03091803Trial NCT03057639Trial NCT03049618Trial NCT03042897Trial NCT02978846Trial NCT02970617Trial NCT02970045Trial NCT02968680Trial NCT02967380Trial NCT02960308

Abstract

Abstract Although much progress has been made with the Human Papilloma Virus (HPV) vaccine, still some communities lag in HPV vaccination rates. Reasons for this vary. HPV vaccination is lowest among Hispanic/Latinos/Latinas(H/L), Asian adolescent boys and H/L adolescent girls of non-US-born parents and for adolescents of African immigrant parents living in the U.S. These include indigenous groups from Latin America (Amerindians) and Africa (Ethiopians, Nigerians, Senegalese) In Los Angeles. LA data show one-fifth of parents from H/L, African ancestry, and Chinese American families (n = 357) high HPV vaccine resistance and over 50% worried about safety or side effects. Research shows low health literacy on HPV related factors, vaccine misconceptions are important factors contributing to low vaccine uptake in these groups. Further, though HPV is not gender-specific, the feminization of HPV with a focus on cervical cancer has been impacted by its sexual transmissibility; and this in turn has influenced the acceptance of HPV related information and its application among boys and men, especially lacking has been information on other HPV related cancers and culturally tailored, age appropriate and in language materials for immigrant origin groups. The USC Norris Comprehensive Cancer Center (USC NCCC) proposes to work on Track 1 (youth and adolescents) to develop and test a communication campaign with culturally and age-tailored educational materials on HPV related cancers and promote initiation of the HPV Vaccine among both male and female adolescent/young adults (10-30ys) in the HL, Chinese and African American/African-origin immigrant communities. We will collaborate with community partners Barrio Action Youth Center, Celebrate Life Black Churches Ministry, Vision y Compromiso, and 7 local FQHC clinics part of Clinicas Monsenor Oscar Romero, and the Chinatown Service Center (CSC), and Vision y Compromiso (promotores de salud). Leveraging USC NCCC Cancer Center COE resources and informed by findings from our previous administrative supplement (Tsui/Baezconde-Garbanati) we will extend our reach to both male and female vulnerable adolescents/young adults (AYA) in diverse audiences. Both quantitative (pre and post campaign) and qualitative data from listening sessions and focus groups will support development of campaign elements and its evaluation. Cultural experts and age-appropriate experts (including adolescents), our Community Advisory Committee and partners will support campaign development. We will use Artificial Intelligence (AI) technology/platforms to produce age and culturally appropriate educational materials in language. Proof of vaccinations will be via medical records review and reports by our FQHC clinics regarding consented participants. Community partners will help identify, train, and establish a community workforce composed of community health educators and promotores de salud for dissemination.

View original record on NIH RePORTER →